Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives

In the present study, a new series of 1,2,3-triazole derivatives was synthesized via a click one-pot reaction. The synthesized compounds were found to be active during molecular docking studies against targeted protein 1T69 by using the Molecular Operating Environment (MOE) software. The designed an...

Full description

Bibliographic Details
Main Authors: Kainat Shafique, Aftab Farrukh, Tariq Mahmood Ali, Sumera Qasim, Laila Jafri, Hisham S. M. Abd-Rabboh, Murefah mana AL-Anazy, Saima Kalsoom
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/7/3104
_version_ 1797607337575317504
author Kainat Shafique
Aftab Farrukh
Tariq Mahmood Ali
Sumera Qasim
Laila Jafri
Hisham S. M. Abd-Rabboh
Murefah mana AL-Anazy
Saima Kalsoom
author_facet Kainat Shafique
Aftab Farrukh
Tariq Mahmood Ali
Sumera Qasim
Laila Jafri
Hisham S. M. Abd-Rabboh
Murefah mana AL-Anazy
Saima Kalsoom
author_sort Kainat Shafique
collection DOAJ
description In the present study, a new series of 1,2,3-triazole derivatives was synthesized via a click one-pot reaction. The synthesized compounds were found to be active during molecular docking studies against targeted protein 1T69 by using the Molecular Operating Environment (MOE) software. The designed and synthesized compounds were characterized by using FT-IR, <sup>1</sup>H-NMR and LC-MS spectra. The synthesized triazole moieties were further screened for their α-amylase and α-glucosidase inhibitory activities. The preliminary activity analysis revealed that all the compounds showed good inhibition activity, ranging from moderate to high depending upon their structures and concentrations and compared to the standard drug acarbose. Both in silico and in vitro analysis indicated that the synthesized triazole molecules are potent for DM type-II. Out of all the compounds, compound K-1 showed the maximum antidiabetic activity with 87.01% and 99.17% inhibition at 800 µg/mL in the α-amylase and α-glucosidase inhibition assays, respectively. Therefore these triazoles may be further used as promising molecules for development of antidiabetic compounds.
first_indexed 2024-03-11T05:29:39Z
format Article
id doaj.art-5b8b7fa5c25043309930f0a401d14494
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T05:29:39Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-5b8b7fa5c25043309930f0a401d144942023-11-17T17:13:35ZengMDPI AGMolecules1420-30492023-03-01287310410.3390/molecules28073104Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole DerivativesKainat Shafique0Aftab Farrukh1Tariq Mahmood Ali2Sumera Qasim3Laila Jafri4Hisham S. M. Abd-Rabboh5Murefah mana AL-Anazy6Saima Kalsoom7SA-Center for Interdisciplinary Research in Basic Sciences, International Islamic University, Islamabad 44000, PakistanDepartment of Physics, PMAS-Arid Agriculture University, Rawalpindi 44000, PakistanHealth Services Academy, Islamabad 44000, PakistanDepartment of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72431, Saudi ArabiaDepartment of Life Sciences, Abasyn University, Islamabad Campus, Islamabad 44000, PakistanChemistry Department, Faculty of Science, King Khalid University, P.O. Box 9004, Abha 61413, Saudi ArabiaDepartment of Chemistry, College of Sciences, Princess Nourah bint Abdulrahman University (PNU), P.O. Box 84428, Riyadh 11671, Saudi ArabiaDepartment of Chemistry, PMAS-Arid Agriculture University, Rawalpindi 44000, PakistanIn the present study, a new series of 1,2,3-triazole derivatives was synthesized via a click one-pot reaction. The synthesized compounds were found to be active during molecular docking studies against targeted protein 1T69 by using the Molecular Operating Environment (MOE) software. The designed and synthesized compounds were characterized by using FT-IR, <sup>1</sup>H-NMR and LC-MS spectra. The synthesized triazole moieties were further screened for their α-amylase and α-glucosidase inhibitory activities. The preliminary activity analysis revealed that all the compounds showed good inhibition activity, ranging from moderate to high depending upon their structures and concentrations and compared to the standard drug acarbose. Both in silico and in vitro analysis indicated that the synthesized triazole molecules are potent for DM type-II. Out of all the compounds, compound K-1 showed the maximum antidiabetic activity with 87.01% and 99.17% inhibition at 800 µg/mL in the α-amylase and α-glucosidase inhibition assays, respectively. Therefore these triazoles may be further used as promising molecules for development of antidiabetic compounds.https://www.mdpi.com/1420-3049/28/7/3104triazole derivativesdiabetes mellitusantidiabetic assay molecular docking
spellingShingle Kainat Shafique
Aftab Farrukh
Tariq Mahmood Ali
Sumera Qasim
Laila Jafri
Hisham S. M. Abd-Rabboh
Murefah mana AL-Anazy
Saima Kalsoom
Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives
Molecules
triazole derivatives
diabetes mellitus
antidiabetic assay molecular docking
title Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives
title_full Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives
title_fullStr Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives
title_full_unstemmed Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives
title_short Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives
title_sort designing click one pot synthesis and antidiabetic studies of 1 2 3 triazole derivatives
topic triazole derivatives
diabetes mellitus
antidiabetic assay molecular docking
url https://www.mdpi.com/1420-3049/28/7/3104
work_keys_str_mv AT kainatshafique designingclickonepotsynthesisandantidiabeticstudiesof123triazolederivatives
AT aftabfarrukh designingclickonepotsynthesisandantidiabeticstudiesof123triazolederivatives
AT tariqmahmoodali designingclickonepotsynthesisandantidiabeticstudiesof123triazolederivatives
AT sumeraqasim designingclickonepotsynthesisandantidiabeticstudiesof123triazolederivatives
AT lailajafri designingclickonepotsynthesisandantidiabeticstudiesof123triazolederivatives
AT hishamsmabdrabboh designingclickonepotsynthesisandantidiabeticstudiesof123triazolederivatives
AT murefahmanaalanazy designingclickonepotsynthesisandantidiabeticstudiesof123triazolederivatives
AT saimakalsoom designingclickonepotsynthesisandantidiabeticstudiesof123triazolederivatives